Peter Vozzo | Investor Relations |
Neil McFarlane | Chief Executive Officer |
Vijay Shreedhar | Chief Commercial Officer |
Chris Prentiss | Chief Financial Officer |
Adrian Quartel | Chief Medical Officer |
Marc Goodman | SVB Leerink |
Lachlan Hanbury-Brown | William Blair |
Jason Butler | JMP Securities |
Stacy Ku | Cowen & Co. |
Zack Sachar | Piper Sandler |
Welcome to the Adamas Pharmaceuticals First Quarter 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Peter Vozzo, Investor Relations representative for Adamas Pharmaceuticals. Please go ahead.
Thank you, Paul, and good afternoon, everyone.